The QualityStocks Daily Stock List
- 4Front Ventures Corp. (FFNTF)
- Abacus Health Products, Inc. (ABAHF)
- Balmoral Resources Ltd. (BALMF)
- Khiron Life Sciences Corp. (KHRNF)
- Leagold Mining Corporation (LMCNF)
- Red Cat Holdings, Inc. (RCAT)
- Sanara MedTech, Inc. (SMTI)
- Innovus Pharmaceuticals, Inc. (INNV)
- PUDO, Inc. (PDPTF)
- Beyond Commerce, Inc. (BYOC)
- Thin Film Electronics ASA (TFECF)
- Prism Technologies Group, Inc. (PRZM)
- China ShouGuan Investment Holding Group Corporation (CHSO)
- Ecosphere Technologies, Inc. (ESPH)
4Front Ventures Corp. (FFNTF)
Penny Stock Hub, New Cannabis Ventures, Small Cap Power, Invest Tribune, Investing News, Midas Letter, Street Insider, Green Market Report, Sweet Dispensary, Market Screener, Freedom Leaf, Investor Ideas, Morningstar, GuruFocus, Stockhouse, and InvestorsHub reported earlier on 4Front Ventures Corp. (FFNTF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.
4Front Ventures Corp. is a cannabis company based in Vancouver, British Columbia. The Company’s team can apply expertise across the value chain - from plant genetics to the cannabis retail experience. 4Front has invested significantly to assemble a wide-ranging collection of management skills and hands-on operating expertise to capitalize on the unique growth opportunity offered by the increased legalization of cannabis. On July 31, 2019, Cannex and 4Front Holdings completed their business combination creating 4Front Ventures. 4Front Ventures lists on the OTC Markets Group’s OTCQX.
Regarding its operational footprint, the Company owns, operates or manages six cultivation and production facilities and 11 retail facilities across eight states. Merger and acquisition discussions are ongoing in the States of California, Nevada, Connecticut, Arizona, and Ohio.
4Front Ventures’ capabilities include Extraction & Production – 20-plus brands and more than 300 SKUs (Stock Keeping Units). Its original cultivation facility in Tumwater, Washington yields 300g/sq. ft. The Company’s new facility in Elma, Washington has demonstrated yields of 400g/ sq. ft. 4Front’s capabilities also include Packaging & Distribution with logistics and distribution to greater than 300 dispensaries in the State of Washington.
During Q2 2019, 4Front Ventures began planting at its new production facility in Worcester, Massachusetts, with the first of what will become perpetual harvests anticipated in Q4 2019. The Company started an optimization project in its Georgetown, Massachusetts production facility that should double cultivation capacity, with the resulting yields expected to begin showing up in Q4 2019 harvests.
Mission is 4Front Ventures' retail division. In Q2 it opened a new dispensary in Rockville, Maryland. It is the third Mission dispensary in Maryland and is the result of a management and licensing relationship with the original license holder.
Brightleaf is 4Front's production division. In Q2 it gained control of the entire 94,000 square foot building in Elk Grove Village, Illinois, where the Company's existing production operation is housed. Design work is under way to support a considerable expansion of that operation in response to the adult-use legislation passed in June of this year.
Recently, Pure Ratios Holdings, a subsidiary of 4Front Ventures unveiled the release of Pure Ratios Essentials. This is a new line of CBD (cannabidiol) capsules formulated with adaptogenic herbs and mushrooms in four distinct formulations: Move, Calm, Think, and Boost. The Pure Ratios Essentials line is the latest offering from the holistic wellness brand, taking an herbalist’s approach to CBD Hemp. Each capsule is formulated with classical Chinese herbs, mushrooms, and 15 mg of water-soluble CBD Hemp.
4Front Ventures Corp. (FFNTF), closed Thursday's trading session at $0.5542, off by 4.4318%, on 153,224 volume with 97 trades. The average volume for the last 3 months is 171,125 and the stock's 52-week low/high is $0.378899991/$2.25.
Abacus Health Products, Inc. (ABAHF)
Cannanbindex.co, OTC Markets, InvestorX, New Cannabis Ventures, Penny Stock Hub, Stockhouse, Dividend Investor, Stockwatch, TradingView, Market Screener, and Investors Hangout reported previously on Abacus Health Products, Inc. (ABAHF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Abacus Health Products, Inc. manufactures and sells over-the-counter (OTC) topical formulations infused with cannabidiol (CBD) extracted from hemp. The Company targets its products at the fast growing markets for topical pain relief and therapeutic skincare. Its products are based on proprietary patent-pending technologies developed by Abacus. Abacus Health Products is the first company to secure OTC registrations for a suite of products blended with CBD hemp extract (Cannabis sativa L). Abacus Health Products is a subsidiary of Aidance Skincare & Topical Solutions, LLC. Abacus lists on the OTC Markets’ OTCQX.
Abacus Health Products was formed with a mission to use CBD hemp extract (Cannabis sativa L) as a conduit to deliver the world’s fastest and most effective pain relief products to millions of people globally. In essence, the Company engages in the development and commercialization of OTC registered topical medications with active pharmaceutical ingredients. These contain organic and natural ingredients, including a cannabinoid-rich hemp extract containing CBD (cannabidiol) from the Cannabis sativa L plant.
Currently, Abacus offers two lines of products. One is CBD CLINIC™, marketed to the professional practitioner market. The other is CBDMEDIC™, marketed to the consumer market. The Company’s products are offered across the United States. They are produced by a contract manufacturer in a cGMP compliant and audited manufacturing facility.
The Company started distribution to healthcare practitioners in 2016 under the CBD CLINIC brand name. In Q3 2018, Abacus launched CBDMEDIC directly to the active fitness and mass retail markets.
CBD CLINIC products are formulated to support fast and lasting relief from joint and muscle pain. A proprietary blend of natural emollients facilitates deeper and quicker absorption of pain-relieving compounds to interrupt pain signaling. In addition, Abacus’ CBDMEDIC products use only naturally-derived analgesic ingredients and 100 percent natural oils to help speed up absorption. The CBDMEDIC line is segmented into three product categories - Active Sport, Back & Neck and Arthritis.
Recently, Abacus Health Products announced the addition of Matrix Distributors, Inc. as a distributor of its CBDMEDIC™ products. Additionally, it announced the expansion of retail stores carrying its products with both new and existing retail partners. Matrix Distributors serves greater than 1,000 independent pharmacies. It will initially roll out 9 CBDMEDIC™ products, including 6 innovative pain relief SKUs (Stock Keeping Units|), Acne Treatment Cream and Cleanser, and Eczema Treatment, to up to 250 locations throughout New York, New Jersey and Pennsylvania during this year, with more roll-outs planned for 2020.
Moreover, Abacus announced the expanded distribution of roughly 225 stores in the Midwest and California. A new retail chain partner, with more than 200 locations in California, will roll out to 125 stores during 2019. An existing retail partner will roll out to an additional 100 stores throughout the Midwest.
Abacus Health Products, Inc. (ABAHF), closed Thursday's trading session at $6.29, up 3.7954%, on 26,343 volume with 126 trades. The average volume for the last 3 months is 9,864 and the stock's 52-week low/high is $5.09081983/$14.00.
Balmoral Resources Ltd. (BALMF)
OTC Markets, Junior Mining Network, News Scanner, Mining.com, Proactive Investors, GlobeNewswire, Northern Miner, Metals News, Investing.com, Mining Feeds, Market Screener, Resource World, Mining Atlas, Stockhouse, Trading View, Wallet Investor, Streetwise Reports, and InvestorsHub reported previously on Balmoral Resources Ltd. (BALMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Balmoral Resources Ltd. is an exploration company exploring a portfolio of gold and base metal properties situated within the prolific Abitibi greenstone belt. Its flagship, 1,000 km2 Detour Gold Trend Project hosts the resource-stage Bug and Martiniere West gold deposits and the Grasset nickel-copper-cobalt-PGE deposit. The Company is led by an experienced and successful Board of Directors and Management team with a lengthy track record of creating shareholder value via the exploration process. OTCQX-listed, Balmoral Resources has its corporate office in Vancouver, British Columbia.
The Company has dual exposure to the gold and nickel sulphide markets. Its gold projects comprise Martiniere, Northshore, N2, Lynx-Rambo, Lac Du Doight, Grasset Gold, Area 52 (Fenelon), Detour Trend, and Vortex Ext. The Company’s nickel projects comprise Grasset, GUC Central, Gargoyle, RUM, Goblin, and Ghost.
Grasset is a Nickel-Copper-Cobalt- PGE Deposit. It is the most advanced of the nickel discoveries made by Balmoral Resources in the Grasset Ultramafic Complex. The Project is 100 percent owned by Balmoral - royalty free. 2018 drilling extended the H1 Zone of the deposit to 800 vertical meters (an increase of more than 300 meters) and planned winter 2020 drilling will target the H3 Zone to a similar depth.
The Grasset Nickel Deposit features some of the highest tenor (nickel content) sulphides in Canada. This allows it to produce extremely high nickel grades. The Company recently announced additional discoveries within the Grasset Ultramafic Complex 7 km to the NW. At the Grasset Nickel Deposit, nickel, copper, cobalt, platinum and palladium are all considered recoverable and payable.
Recently, Balmoral Resources announced that it expanded the ongoing Phase 1 drill program testing the Area 52 gold target on its Fenelon Property in the Province of Quebec. The program has been expanded from the earlier announced 1,200 meters to about 2,000 meters and may be further expanded as drilling progresses. Balmoral has completed two drill holes so far with a third in progress. It has 21 permitted drill sites in Area 52.
Last month, Balmoral Resources announced that, following the recent discovery of precious metal-rich nickel sulphide mineralization on its RUM North Property, it has acquired by staking three new nickel sulphide targets alike to the intrusion hosting the Bluenose discovery. Balmoral now controls 15 individual ultramafic intrusive targets, covered by six separate properties, in the Lac Rocher nickel district in Central Quebec.
This week, Balmoral Resources announced that it resumed drilling in Area 52 on its Fenelon Property, part of its larger Detour Gold Trend Project in Quebec. Area 52 encompasses an extensive, untested segment of the Sunday Lake deformation zone, the southern extension of the recently identified Area 51 corridor, and the intersection of these two gold bearing structural zones. The Sunday Lake deformation zone is the crustal scale, east-west trending fault system that controlled the emplacement of the nearby, greater than 20 million ounce Detour Lake gold deposit.
Balmoral Resources Ltd. (BALMF), closed Thursday's trading session at $0.1799, off by 0.277162%, on 408,927 volume with 71 trades. The average volume for the last 3 months is 138,623 and the stock's 52-week low/high is $0.065700002/$0.195999994.
Khiron Life Sciences Corp. (KHRNF)
NetworkNewsWire, Financial Content, GlobeNewswire, Investor Ideas, Wallmine, Stockhouse, Proactive Investors, Investing News, Wallet Investor, Midas Letter, Micro Small Cap, Dividend Investor, New Cannabis Ventures, Market Screener, PotStockNews, PR Newswire, InvestorsHub, Virtual Investor Conferences, and Insider Financial reported beforehand on Khiron Life Sciences Corp. (KHRNF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Khiron Life Sciences Corp. is an integrated cannabis company with core operations in Latin America. Khiron is fully licensed in the country for the cultivation, production, domestic distribution, and international export of THC (tetrahydrocannabinol) and CBD (cannabidiol) medical cannabis. OTCQB-listed and established in 2017, Khiron Life Sciences has its head office in Toronto, Ontario.
The Company combines worldwide scientific expertise, agricultural advantages, branded product market entrance experience and education to increase prescription and brand loyalty to address priority medical conditions, including chronic pain, epilepsy, depression and anxiety in the Latin American market.
Khiron provides investor exposure to the rapidly legalizing cannabis markets in Latin America. The Company is leveraging its technical capabilities and agricultural advantages to secure a competitive position in global markets.
Khiron Life Sciences has operations in three countries in Latin America - Colombia, Chile and Uruguay. Its core operations are in Colombia. Khiron’s capacity to export THC and CBD extracts (medicinal from Colombia) and dry flower (from Uruguay), permits it to take advantage of low-cost cultivation to engage in the $140 billion European market. Distribution channels of branded products include medical products distribution by way of wholly-owned clinics and wellness Latin American and U.S. retail distribution.
Last week, Khiron Life Sciences announced that it started construction of a 9,800 m2 (105,486 sq. ft.) cultivation and processing facility in Juan Lacaze, Uruguay. With a production capacity of 17 tons annually, Khiron's investment in this state-of-the-art facility represents a major increase in the Company's total production capacity, strengthening its ability to export and supply cannabis to key global markets, including Brazil and Europe. Construction is underway. Completion is scheduled for mid Q3 2020.
This facility will include 8,000 m2 of covered area for cultivation, where controlled conditions of irrigation, temperature, humidity and light will be implemented for optimum crop development. In addition, a 1,800 m2 processing plant will be constructed on site for drying and processing crops, with pharmaceutical-grade design standards in place to ensure quality control across the analysis process.
Khiron Life Sciences Corp. (KHRNF), closed Thursday's trading session at $1.19, off by 2.451%, on 221,335 volume with 197 trades. The average volume for the last 3 months is 165,976 and the stock's 52-week low/high is $0.84979999/$3.27999997.
Leagold Mining Corporation (LMCNF)
OTC Markets, StreetWise Reports, Junior Mining Network, Stockhouse, Morningstar, Northern Miner, Baystreet, NewstoWatch, Ceo.ca, Metals News, InvestorsHub, 4-Traders, StockInvest.us, and Resource World reported previously on Leagold Mining Corporation (LMCNF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Leagold Mining Corporation is a mid-tier gold producer headquartered in Vancouver, British Columbia. The Company focuses on opportunities in Latin America. Leagold formerly went by the name HTI Ventures Corp. It changed its corporate name to Leagold Mining Corporation in August of 2016. Leagold Mining’s shares trade on the OTC Markets Group’s OTCQX.
Leagold owns four operating gold mines in Mexico and Brazil. In addition, it has an expansion opportunity in Mexico and a near-term gold mine restart project in Brazil. Leagold Mining has an inventory of 7.1 million ounces of gold reserves from which to grow. The Company’s operating mines are Los Filos, RDM, Fazenda, and Pilar. Its development projects are the Los Filos expansion and Santa Luz.
The expectation is that Leagold Mining’s four gold mines in Mexico and Brazil will collectively produce 380,000-420,000 oz gold in 2019 at an all-in sustaining cost (AISC) of $920-970/oz. In 2018, the Company produced 302,550 oz gold – in line with guidance of 295,000- 305,000 oz.
Last month, Leagold Mining reported Q2 and H1 2019 financial and operating results. Consolidated gold production for the six months ended June 30, 2019 was 197,234 oz at AISC of $951/oz sold. This resulted in an AISC margin of $65.9 million. Six-month sales of 201,724 oz produced H1 2019 revenue of $258.3 million, earnings from mine operations of $44.2 million, and EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of $67.3 million.
The Company’s Los Filos mine complex expansion preparations were under way in Q2 starting in July. The first task is the development of an additional vent raise followed by lateral development on key mine infrastructure, extending beyond the 1,330-meter access ramp that was completed in November of last year. An access road for the Guadalupe open pit is being prepared; stripping is scheduled to commence in Q4 2019.
Leagold Mining has started a 24,000-meter drill program in the Guadalupe area. This drill program is to convert inferred resources to indicated resources and measure the potential to steepen pit slopes. These programs will potentially add to reserves and lower the overall strip ratio.
Leagold Mining Corporation (LMCNF), closed Thursday's trading session at $2.1072, off by 3.5651%, on 398,817 volume with 547 trades. The average volume for the last 3 months is 282,759 and the stock's 52-week low/high is $0.949999988/$2.32999992.
Red Cat Holdings, Inc. (RCAT)
TipRanks, Financial Buzz, TeleTrader, Investing News, Street Insider, Streetwise Reports, Spotlight Growth, Stockwatch, PR Web, Dividend Investor, Investors Hangout, Stockhouse, TradingView, GlobeNewswire, Nasdaq, Simply Wall St, Global Banking and Finance, and InvestorsHub reported earlier on Red Cat Holdings, Inc. (RCAT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Red Cat Holdings, Inc. is a foremost provider of secure blockchain-based distributed storage, analytics and SaaS (Software-as-a-Service) for the drone industry. The Company provides solutions for regulators to track and review flight data, insurance companies to insure drones, and pilots to become compliant with regulations.
The Company lists on the OTC Markets. Red Cat is based in San Juan, Puerto Rico. This past May, Red Cat announced the successful completion of a reverse merger with TimeFireVR, d/b/a TeraForge.
Fundamentally, Red Cat’s emphasis is on technology to make drones trackable, accountable, and the skies a safer place. The Company is the leading provider of distributed data storage, analytics and services for the growing recreational and commercial drone industry.
Regarding its Blockchain Blackbox, Red Cat’s black box drone flight recorder is the first distributed system with security and encryption that regulators and insurance companies can trust. The Company’s drone analytics and storage enable flight replay with customizable reports that can determine fault or performance issues.
Furthermore, the Company has partnered with UPR Mayagüez on a research program to develop an open sourced based flight controller (RISC V Flight Controller) with the world’s fastest open source RISC V processor. The System permits Red Cat to embed the software into hardware. This gives the flight controller 10x the performance of existing flight controllers.
Red Cat’s team is lead by Mr. Jeff Thompson. Mr. Thompson is a serial entrepreneur who has founded two successful technology start-ups. He is the Founder of Edgenet, which was sold to Citadel broadcasting in 1997. He is the Co-founder of Towerstream (public 2007 NASDAQ).
In April 2019, Red Cat became a founding member of the First Person View (FPV) Freedom Coalition after the coalition’s official launch as a 501(c)(3) organization. Being part of the coalition, Red Cat will continue advocating for airspace for recreational drone pilots and FPV operators, provide safety and education guidelines compliant with the FAA (Federal Aviation Administration), and integrate the FPV community into the regulatory framework as an FAA community-based organization (CBO).
In May, Red Cat announced the appointment of Mr. Nicholas Liuzza Jr. and Mr. Patrick R. Mitchell to its Board of Directors. Mr. Liuzza Jr. is currently the Executive Vice President of Real Matters, Inc. Real Matters is a network management services provider for the mortgage lending and insurance industries. Mr. Liuzza Jr. has held this position from April of 2016 to the present.
Mr. Patrick R. Mitchell is the Chief Executive Officer of The Carpenter Health Network, a foremost health care provider in the Gulf Coast region providing a range of services. These services include nursing, home care, hospice, as well as rehabilitation care. In 2002, Mr. Mitchell founded St. Joseph Hospice with the mission of providing peace, comfort and dignity to those facing terminal illness.
Red Cat Holdings, Inc. (RCAT), closed Thursday's trading session at $2.50, up 38.1215%, on 1,513 volume with 11 trades. The average volume for the last 3 months is 963 and the stock's 52-week low/high is $1.14999997/$12.1999998.
Sanara MedTech, Inc. (SMTI)
Zacks, Stock Chortle, TipRanks, Market Screener, StocksNewsFeed, Digital Journal, Stockwatch, Investors Hangout, Simply Wall St, TradingView, Investing.com, Stockhouse, and InvestorsHub reported beforehand on Sanara MedTech, Inc. (SMTI), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Sanara MedTech, Inc. is a provider of surgical and chronic wound care products dedicated to improving patient outcomes. The Company develops, markets and distributes biotechnology products to physicians, hospitals, clinics, and all post-acute care settings. Sanara focuses on developing and commercializing products in the areas of skin and wound care, including biofilm management. Biofilm management is an important step in the wound healing process.
The Company formerly went by the name WNDM Medical, Inc. It changed its name to Sanara MedTech, Inc. in May of this year. Sanara MedTech is based in Fort Worth, Texas and the Company lists on the OTCQB.
Sanara MedTech sells and distributes CellerateRX® Surgical Activated Collagen® Adjuvant, HYCOL™ Hydrolyzed Collagen, BIAKŌS™ Antimicrobial Skin & Wound Cleanser, and PULSAR II™ Advanced Wound Irrigation System (AWI™). CellerateRX helps to provide a favorable environment for healing. The Activated Collagen® in CellerateRX® Surgical Powder is changing collagen’s role in the operating room. CellerateRX’s® patented Activated Collagen fragments (CRXα®) are a fraction of the size of the native collagen molecules and particles found in other products. They provide the benefits of collagen to the body.
Sanara MedTech’s products sell in the North American advanced wound care and surgical tissue repair markets. The Company continues to seek long-term strategic partnerships with a focus on products that complement its existing portfolio and provide more effective outcomes at a lower overall cost.
Recently, Sanara MedTech announced the election of Dr. Kenneth Thorpe and Ms. Ann Beal Salamone to its Board of Directors. Kenneth E. Thorpe, Ph.D., is the Robert W. Woodruff Professor and Chair of the Department of Health Policy & Management, in the Rollins School of Public Health of Emory University, Atlanta, Georgia. He was the Vanselow Professor of Health Policy and Director, Institute for Health Services Research at Tulane University.
Ann Beal Salamone, M.S. has focused on wound care since 1986. She is a member of the National Academy of Engineering and The Academy of Medicine, Engineering & Science of Texas (TAMEST). She has developed products for electronics, water purification, personal care and healthcare and has invested in and served on the Boards for a number of entrepreneurial companies and also co-founded six companies.
Sanara MedTech, Inc. (SMTI), closed Thursday's trading session at $7.60, up 10.1449%, on 110 volume with 2 trades. The average volume for the last 3 months is 2,379 and the stock's 52-week low/high is $2.00/$9.10000038.
Innovus Pharmaceuticals, Inc. (INNV)
NetworkNewsWire, Zacks, Street Insider, Micro Cap Daily, Stockwatch, StreetWise Reports, Marketbeat, OTC Markets, Stockaholics, Insider Financial, GlobeNewswire, Simply Wall St, 4-Traders, and Stockhouse reported beforehand on Innovus Pharmaceuticals, Inc. (INNV), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Innovus Pharmaceuticals, Inc. is an emerging commercial-stage pharmaceutical company based in San Diego, California. The Company delivers safe, innovative and effective over-the-counter (OTC) medicine and consumer care products to improve men’s and women's health and respiratory diseases. Its dedication is to being a leader in developing and marketing new OTC and branded Abbreviated New Drug Application (ANDA) products. Established in 2008, Innovus Pharmaceuticals lists on the OTCQB.
The Company is pursuing opportunities where existing prescription drugs have recently, or are expected to, change from prescription (Rx) to OTC. Innovus delivers unique and innovatively presented and packaged health solutions via its OTC medicines and consumer and health products that it markets directly, via commercial partners to primary care physicians, urologists, gynecologists and therapists, and directly to consumers via its on-line channels, retailers and wholesalers.
Innovus Pharmaceuticals has products for a range of indications. These include Brain Health, Diabetes, Fertility, Men’s Health, Pain Management, Respiratory, Vitality, Vision, and Women’s Health.
Recently, Innovus Pharmaceuticals announced that it has made major progress on the regulatory and manufacturing steps required to obtain market authorization from Health Canada to commercialize its FlutiCare® brand in Canada. It expects to secure the needed market authorization, manufacturing and supply of the product from an existing Canadian manufacturer during the second half of 2019 pending Health Canada approval. The product is expected to be available as an OTC in that country and will not require a prescription.
In addition to FlutiCare®, Innovus recently jointly announced with its former distribution partner, Acerus Pharmaceuticals, Inc., that it would be receiving back all the rights to its product UriVarx®, approved for the relief of symptoms of overactive bladder and urine incontinency, by Health Canada. Innovus Pharmaceuticals has 13 products approved and commercialized in Canada. These include Zestra®, Zestra Glide®, Uxor®, DiabaSens®, Vesele®, RecalMax®, UriVarx®, ProstaGorx®, BH Testosterone®, AllerVarx®, Xyralid® Cream, Xyralid® Suppositories, and Apeaz®. The Company has filed or is in the process of filing for six additional products including, FlutiCare®, PeVarx®, Healthifeet®, Breastlift®, ArthriVarx® and CarvaNum™.
Recently, Innovus Pharmaceuticals announced that its Delta Prime Savings Club™ E-commerce marketplace (DPSC) is on course for annual sales of roughly $3 million. The DPSC, one of Innovus’ primary E-Commerce marketplaces, was purchased by the Company in early 2019 for approximately $35,000 plus approximately $300,000 in inventory. It specializes in selling numerous kinds of consumer products in addition to Innovus’ OTC ANDA and supplement products and other general consumer care products.
Innovus Pharmaceuticals, Inc. (INNV), closed Thursday's trading session at $2.39, up 60.4027%, on 99,500 volume with 210 trades. The average volume for the last 3 months is 3,240 and the stock's 52-week low/high is $1.04999995/$13.6499996.
PUDO, Inc. (PDPTF)
Penny Stock Tweets, Stockwatch, Capital Cube, Financial Content, MarketWatch, Infront Analytics, YCharts, The Street, InvestorsHub, Market Screener, Stockreads, Penny Stock Hub, GuruFocus, Investorx, The Wall Street Analyzer, Stockhouse, Morningstar, Wallet Investor, Barchart, Otc.watch, and 4-Traders reported earlier on PUDO, Inc. (PDPTF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
PUDO, Inc. is North America's first carrier-neutral Pick-Up Drop-Off Network. It is developing North America's only carrier-neutral parcel pick-up/drop-off technology and logistics network as a way of solving the last-mile parcel-traffic-control gridlock. Recently, the Company was named one of the Top 20 most innovative public technology companies by the Canadian Innovation Exchange. Established in 2015, PUDO is headquartered in Mississauga, Ontario.
PUDO’s team of logistics and parcel traffic management experts have created a market intelligence and trends driven solution. This comprises carrier-neutral plug-and-play technology for desktop and mobile, plus a strategically located network of parcel pick-up and drop-off PUDOpoints for pay-as-you-go use by all players within the e-commerce environment.
The Company's technology and network virtually eliminates expenses associated with second-attempt deliveries, un-attended parcel theft and spoilage, and mismanaged reverse logistics on returns. PUDO’s technology and network provides carriers, retailers, and consumers with needed cost controls, choice, and convenience.
A PUDO Point™ is a convenience store usually within minutes of one’s location. It will accept one’s shipments for them and be there when they are ready to pick them up. There are thousands of PUDO-authorized dealer pickup and drop-off locations across the U.S. and Canada.
Concerning e-commerce and return logistics, PUDO offers complete and cost-effective return logistics programs for its eRetailers and corporations. The Company has a distributed and remote work force across the U.S. and Canada.
PUDO has signed an Agreement with global third-party logistics company Landmark Global, Inc. (LGI), part of the bpost group, to undertake a mutually beneficial arrangement for LGI and its customers to use PUDO's Network of parcel pick-up and drop-off locations, to enhance the last-mile e-commerce parcel delivery experience in Canada on Landmark Global's new Sprintstar network. Using the PUDO network of services, Landmark Global will be able to expand its Sprintstar service to many communities not previously served.
Recently, PUDO announced that it filed interim financial results (unaudited) and operational highlights for its Q3 ended November 30, 2018 . The Company stated that it has gained considerable ground during this period in keeping with its refined emphasis on strategic key markets and partners capable of facilitating exponential growth.
Parcel volumes for the quarter ended November 30, 2018 increased a significant 16.9 percent more than the equivalent quarter the prior year. Parcel volumes in Q3 FY 2019 increased 27.6 percent from those in Q2 FY 2019. During FY 2018, the change in parcel volumes between Q2 and Q3 comprised a 10.4 percent increase.
PUDO, Inc. (PDPTF), closed Thursday's trading session at $0.664, up 232%, on 300 volume with 2 trades. The average volume for the last 3 months is 537 and the stock's 52-week low/high is $0.128000006/$1.23000001.
Beyond Commerce, Inc. (BYOC)
Zacks, OTC Markets, Penny Stock Tweets, Stockhouse, InvestorsHub, YCharts, Street Insider, Market Screener, Wallet Investor, Simply Wall St, Financial Content, MarketWatch, Investors Hangout, Barchart, The Street, Tip Ranks, 4-Traders, GuruFocus, Stockopedia, OTC.Watch, TradingView, Morningstar, Insider Financial, and Stockinvest reported earlier on Beyond Commerce, Inc. (BYOC), and we also report on the Company, here at the QualityStocks Daily Newsletter.
Beyond Commerce, Inc. is a planned provider of B2B (Business to Business) internet marketing analytics, technologies, and related services. The Company’s planned objective is to develop, acquire, and deploy disruptive strategic software technology that will build on organic growth potential. Additionally, its planned goal is to exploit cross-selling opportunities. Beyond Commerce is based in Las Vegas, Nevada. The Company’s shares trade on the OTC Markets Group’s OTCQB.
The Company operates as a holding enterprise that focuses on “big data” companies in the global B2B Internet Marketing Analytics/Technology and Services space. Beyond Commerce plans to provide a cohesive digital product and services platform. This is to provide clients with a single point of contact for their big data, marketing and related sales initiatives. The Company’s emphasis is to develop, acquire, and also deploy disruptive strategic software technology and market-changing business models through acquisition or organic growth.
In August of 2018, Beyond Commerce announced that it was added to the LD Micro Index effective August 1, 2018. Beyond Commerce Chairman and Chief Executive Officer, Mr. George Pursglove, said at that time, "This is an exciting time for us as we continue to execute on business milestones which are translating into additional exposure in the capital markets and building on our goals for corporate transparency and credibility with stakeholders. LD Micro has championed the microcap space and I am proud that we have been included in their index and to be recognized with other successful peers in the microcap space."
Recently, Beyond Commerce announced that it signed a definitive business combination agreement with PathUX, LLC. Beyond Commerce Chairman and Chief Executive Officer, Mr. George Pursglove, said, "PathUX provides Cloud based marketing automation software and will make a great addition to our future vision, has recurring revenues and a great team. We look forward to our future growth plans together. We expect the provisions of the agreement to be implemented in the second quarter of 2019.”
Beyond Commerce, Inc. (BYOC), closed Thursday's trading session at $0.0027, up 50.00%, on 16,958,648 volume with 121 trades. The average volume for the last 3 months is 6,454,441 and the stock's 52-week low/high is $0.001099999/$0.097450003.
Thin Film Electronics ASA (TFECF)
Speculating Stocks, Dividend Investor, Wallet Investor, Penny Stock Millionaire, Penny Stock Tweets, Stockhouse, TradingView, OTC Markets, InvestorsHub, The Street and 4-Traders reported earlier on Thin Film Electronics ASA (TFECF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Thin Film Electronics ASA provides near field communication (NFC) mobile marketing and smart-packaging solutions by printed electronics technology. It provides end-to-end mobile marketing solutions that feature hardware, label/packaging integration services, and a robust cloud-based software platform.
OTCQX-listed, Thin Film Electronics is based in Oslo, Norway. Additionally, the Company has offices in Silicon Valley, Sweden, San Francisco, London, and Shanghai.
Thin Film’s vision is to make everyday items ‘just smart enough’, thus, effectively extending the traditional boundaries of the IoT to create the Internet of Everything. The Company has 270 patents and patents-pending.
Thin Film’s products include NFC Solutions. NFC involves hardware and software designed with volume production in mind. NFC Solutions is built on highly scalable printed electronics technology. NFC features OpenSense™ Technology - Dual-ID tag with sealed/opened sensor. In addition, it features SpeedTap™ Technology - Single-ID tag.
Moreover, Thin Film’s products include EAS Tags. These are for retailers to strengthen their retail loss-prevention programs with next-generation anti-theft tags. The Company’s 8.2MHz tags are compatible with globally installed infrastructure. Integrated EAS maximizes product availability and minimizes loss. EAS Tags also reduce overhead associated with hard tag application and removal.
Recently, Thin Film announced it received the IDTechEx Technical Development in Manfacturing award in recognition of its pioneering roll-to-roll printed electronics fab in San Jose, California. The IDTechEx Awards were presented as part of the Printed Electronics USA 2018 conference. They recognize company development and success in the field of printed electronics.
The Technical Development in Manufacturing award recognizes the most significant development of a manufacturing device, process, or production plant in the industry over the last 24 months. Award recipients must demonstrate the optimization of a lab-scale or mass-scale production process through improving productivity, quality, reliability, uniformity, or scale.
Thin Film’s San Jose facility features a 22,000 sq-ft printed electronics factory, which is the world’s first production roll-to-roll (R2R) printed electronics line using stainless steel substrates. The design of the fab is for an annual production capacity of up to seven billion units. It is optimized to enable production of low-cost, mechanically strong devices enabling high-volume applications. This includes NFC (near field communication) for mobile marketing, authentication, as well as supply chain services.
Thin Film Electronics ASA (TFECF), closed Thursday's trading session at $0.01, up 66.6667%, on 10,000 volume with 1 trade. The average volume for the last 3 months is 21,548 and the stock's 52-week low/high is $0.006/$0.156790003.
Prism Technologies Group, Inc. (PRZM)
Zacks, Wall Street Journal, TradingView, MarketWatch, and InvestorsHub reported on Prism Technologies Group, Inc. (PRZM), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Prism Technologies Group, Inc. is an intellectual property (IP) licensing and technology research & development (R&D) company. The Company, by way of its wholly-owned subsidiaries, owns a patent portfolio consisting of nine patent families incorporating 61 issued and six pending patents in the Computer & Network Security, Semiconductors, and Medical Technology arena.
Established in 1995, Prism Technologies Group is the parent company of Prism Technologies, LLC, which is a Nebraska Limited Liability Company (LLC) based in Omaha, Nebraska. Prism Technologies Group has its corporate office in Folsom, California.
The Company previously went by the name Internet Patents Corporation. It changed its name to Prism Technologies Group, Inc. in September of 2015. The Company lists on the OTC Markets Group’s OTCQB.
Prism Technologies Group licenses and enforces a portfolio of patents relating to its technologies. It continues to develop and patent new technologies.
The Company’s dedication is to continuing R&D efforts in a number of fields. Its mission is to continue to develop and invent new technologies in computer and network security, wearable computing, transaction processing, and healthcare to speed up time to market opportunities for its clients.
Prism Technologies Group’s Executive Team includes Mr. Hussein A. Enan - Chairman, Chief Executive Officer; and Mr. Greg Duman - President, Prism Technologies, LLC and member of Prism Group's Board of Directors. Mr. Duman chairs the Audit Committee.
Prism Technologies Group announced in October of 2017 that it entered into an Asset Purchase Agreement with Amorphous Technologies International (ATI). ATI is a leader in the development of innovative amorphous alloy solutions based on proprietary materials technology. Its solutions deliver value through removing the limits of existing materials technology, which result in high costs throughout the lifecycle of a product.
The Agreement is to acquire certain intellectual property (IP) assets related to unique uses for amorphous metals. After the close of the transaction, Prism will commercialize the acquired IP assets to create new amorphous metal technology offerings for the consumer electronics, automotive, industrial, and other business sectors.
Prism Technologies Group, Inc. (PRZM), closed Thursday's trading session at $0.05186, up 47.7493%, on 1,000 volume with 1 trade. The average volume for the last 3 months is 1,571 and the stock's 52-week low/high is $0.0151/$0.200000002.
China ShouGuan Investment Holding Group Corporation (CHSO)
OTC Markets, MarketWatch, InvestorsHub, Morningstar, GuruFocus, and StreetInsider reported on China ShouGuan Investment Holding Group Corporation (CHSO), and today we report on the Company, here at the QualityStocks Daily Newsletter.
China ShouGuan Investment Holding Group Corporation, with equity investment as its core, and operational entities as its foundation, is a large-scale integrated Investment holding Group. The OTCQB-listed Company has expanded its business layout that covers its investment bank business, the new energy industry, the environmental protection and energy-saving industry, the mining industry, the health industry, and also the hi-tech industry and more. Incorporated in 2010, China ShouGuan Investment Holding Group Corporation is based in Shenzhen, China.
Regarding mining, China ShouGuan is a gold mining exploration, development, and advisory Company in the gold rich zones of Shandong and HeiLongJiang Provinces in the People’s Republic of China (PRC). The Company’s emphasis is acquiring or leasing under-performing mines in major mineral zones. It then finances their expanded exploration and production utilizing industry leading technologies.
China ShouGuan’s projects include the Dayuan Gold Mine, which covers an area of 0.3475 square kilometers in Longkou city of Shandong; and the mine in the Daxinganling area in Heilongjiang Province in the northeastern part of China.
China ShouGuan also provides mining technical advisory services. Moreover, the Company provides consulting services in the areas of geological analysis and mine exploration. The range of its mining business encompasses exploration, mining, beneficiation and technical consultation. Its principal business is gold mining, with geological prospecting and technical consultation as supplementary services.
China ShouGuan Investment Holding Group is diversifying its business. The Company has its Pro-Environment; Eco-Agriculture; Health, and Investment initiatives. Pertaining to Pro-Environment, it entered into the environmental protection field through beginning with sewage sludge treatment and disposal. Relying on its ion fractionation sewage sludge treatment technology, the Company provides integral services for sewage sludge treatment projects.
Regarding Eco-Agriculture, the agricultural company affiliated to Shouguan Group is one of the first companies to introduce and plant, and also work on product research of the Melaleuca tree in China. Concerning Health, China Shouguan’s commitment is to the development of the health industry, along with setting up funding and concentrating on the development of life sciences, health products, and investing in the health industry. Additionally, the Investment business line of China Shouguan covers industrial investment, financial investment, private equity fund management, investment banking services, and more.
China ShouGuan Investment Holding Group Corporation (CHSO), closed Thursday's trading session at $0.02, up 50.3759%, on 1,000 volume with 1 trade. The average volume for the last 3 months is 33,689 and the stock's 52-week low/high is $0.004999999/$0.090000003.
Ecosphere Technologies, Inc. (ESPH)
TheMicrocapNews, PennyStocks24, Buzz Stocks, Penny Pick Finders, PennyStockProphet, SmallCapVoice, Wall Street Resources, Planet Penny Stocks, SecretStockPromo, and StockOnion reported earlier on Ecosphere Technologies, Inc. (ESPH), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Ecosphere Technologies, Inc. is a development and Intellectual Property (IP) licensing company. It develops environmental solutions for global water, energy, industrial, and agricultural markets. The Company helps industry increase production, lessen costs, and protect the environment through a portfolio of inventive, patented technologies and exclusive and nonexclusive licensing opportunities across a wide spectrum of industries and applications globally. Ecosphere Technologies is based in Stuart, Florida.
Ecosphere has a wide-ranging portfolio of patented clean technologies. These can be purchased and licensed for use in large-scale and sustainable applications across industries, nations, and ecosystems. The Company’s technologies include the Ecos PowerCube®, the Ecos GrowCube™, and Ozonix®.
The Ecosphere technologies and products are available via many brands and subsidiaries. These include Sea of Green Systems, Ecosphere Development Company, and Fidelity National Environmental Solutions. The Company’s goal is to help clean energy producers’ gain more control over their water resources, quality, and completion costs through providing effective mobile water recycling solutions.
The Ecosphere Ozonix® Technology provides a chemical-free alternative to high-volume water recycling for a varied range of applications. These range from the oil & natural gas industry and mining to agriculture and municipal wastewater treatment. The oil and natural gas industry is successfully using Ecosphere Technologies’ patented Ozonix® technology to treat and recycle the water used in oil and natural gas well drilling and completion programs.
The Ecos PowerCube® is the world’s largest, mobile, solar-powered generator. It runs on high power photovoltaic panels. These panels extend from its container combined with an easy to set up wind turbine. Energy is stored in onboard batteries.
The Ecos GrowCube® is a state-of-the-art, turn-key, fully-automated "greenhouse". It uses hydroponic growing techniques to maximize the amount of crop production possible in a given footprint. The Ecos GrowCube® incorporates Ecosphere’s patented Ozonix® water treatment technology. In addition, Ecosphere has its Ozonix Sentinel. This is the world's first line of water treatment vessels for cleaning up endangered rivers and lakes.
Sea of Green Systems (SOGS), a subsidiary of Ecosphere Technologies, announced in January 2017 the launch of its SOGS-650X, Full Spectrum LED Growing Light. This light was developed to provide growers with an engineered solution to maximize vegetative growth and flower production for the indoor agriculture and legal marijuana industries.
The SOGS-650X can produce greenhouse-like conditions through providing an average 25 DLI (Daily Light Integral) during the Vegetative and Flowering Cycles, with about 450-650 uMols and 700-900 uMols at the plant canopy during their respective growth cycles. Sea of Green Systems (SOGS) sells high-tech growing equipment, lighting solutions, and nutrients to the Precision Agriculture industry.
Recently, Sea of Green Systems announced that its sublicensee in the agricultural industry, Gulf Coast Organics (GCO), signed an agreement with Wedgworth's, Inc., to be the exclusive distributor in Florida for its Amp Agronomy™ plant nutritional line. Wedgworth's is recognized as Florida's largest custom fertilizer dealer since 1932. Wedgworth's provides custom blended agricultural plant nutrient products across Florida to help farms grow and prosper. CAVISONIX®, developed by SOGS and Ecosphere Technologies, utilizes ultrasonic cavitation to treat fertilizers for increased plant availability.
Ecosphere Technologies, Inc. (ESPH), closed Thursday's trading session at $0.0025, up 38.8889%, on 177,474 volume with 4 trades. The average volume for the last 3 months is 145,161 and the stock's 52-week low/high is $0.0005/$0.018899999.
The QualityStocks Company Corner
- INmune Bio Inc. (NASDAQ: INMB)
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF)
- HTC Extraction Systems (TSX.V: HTC)
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF)
- VPR Brands, LP (VPRB)
- Sugarmade, Inc. (SGMD)
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- Cannabis Strategic Ventures, Inc. (NUGS)
- Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G)
- Marijuana Company of America (OTCQB: MCOA, MCOAD)
- Grapefruit Boulevard Investments Inc. (IGNG)
- Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P)
- Neutra Corp. (OTCQB: NTRR)
INmune Bio Inc. (NASDAQ: INMB)
INmune Bio (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced its receipt of United States Patent and Trademark Office (“USPTO”) formal notice of allowance to Patent Application Serial No. 15/776,061. To view the full press release, visit: http://nnw.fm/ULr9Z.
INmune Bio Inc. (NASDAQ: INMB) is a diversified clinical-stage immunology company developing novel therapies that target distinct parts of a patient's innate immune system to fight disease. Drug candidates INKmune™ and INB03 may be used to treat cancer while XPro1595 targets neuroinflammation as a cause of Alzheimer's disease. INmune Bio's product platforms utilize a precision therapy approach to promote the body's innate immune response to treat unsolved problems in medicine.
INmune Bio is the first biotechnology company to close an initial public offering (IPO) in 2019 and commence trading on The Nasdaq Capital Market. The company also received a "Part the Cloud" award from the Alzheimer's Association in 2018 which included a $1 million grant to advance INmune Bio's XPro1595 drug candidate.
INmune Bio's product pipeline targets three segments of concern:
- Alzheimer's disease/dementia claims 5.5 million patients in the United States. INmune Bio views Alzheimer's as an immunologic disease which changes the drug discovery process, changes the way clinical trials are designed, and may provide hope for patients and caregivers.
- Cancer residual disease which is expected to generate more than 1.7 million new cases yearly with an estimated 609,640 fatalities. INMB believe that converting resting Natural Killer ("NK") cells to primed NK cells, which kill cancerous cells on contact, is an important therapeutic strategy to help clear residual disease.
- Resistance to immunotherapy. By preventing the proliferation and function of cells that resist immunotherapy, patients should have a stronger immune response to cancer cells and may respond better to other cancer treatments including immunotherapy and live longer.
INmune Bio Drug Candidates and Clinical Programs
INKmune is a biologic delivery system that primes a patient's resting NK cells to kill cancer. INKmune targets residual disease for patients that have completed initial cancer therapy (surgery, radiation and/or chemotherapy) and have a low burden of disease with a high risk of relapse.
In late 2019, INKmune will start enrolling patients in a phase I/II trial for women with relapsed refractory ovarian cancer. In many patients, cancer relapse after seemingly effective cancer therapy is due to a failure of the patients own NK cells to eliminate minimal residual disease ("MRD").
Using a novel mechanism of action and a precision medicine approach, INKmune therapy should enhance NK cells' ability to eliminate residual disease.
INB03 is a checkpoint inhibitor that targets myeloid derived suppressor cells ("MDSC") which can produce an immunosuppressive shield that prevents a patient's own immune system from attacking the cancer. INmune Bio is currently completing a monotherapy INB03 phase I trial in patients with advanced solid tumors. The INB03 program will transition into a combination therapy clinical program in the summer of 2019 to prepare for a phase II trial in patients resistant to checkpoint inhibitors due to increased MDSC.
Treatment with INB03 should eliminate MDSC in the tumor microenvironment to allow checkpoint inhibitors to be therapeutically effective.
XPro1595 targets the microglial immune cells of the brain that are activated in many Alzheimer's disease patients. These microglial cells are a cause of neuroinflammation that can kill nerve cells and promote synaptic dysfunction – the cause of dementia in Alzheimer's.
The three-month, phase I trial is expected to enroll 18 patients in summer of 2019. It is designed to measure traditional and novel biomarkers of inflammation in patients with mild to moderate Alzheimer's disease who have neuroinflammation. The trial is supported by a $1 million "Part the Cloud" grant from the Alzheimer's Association. Inflammation, especially chronic inflammation, is being recognized as an important part of the pathology of many diseases including cancer and Alzheimer's disease.
Dr. RJ Tesi, M.D., INmune Bio co-founder, CEO and acting chief medical officer, has been a licensed physician since 1982 and a Fellow of the American College of Surgery since 1991. He received his medical degree from Washington University School of Medicine in 1982 and has served many roles in several development-stage biotech companies focused on treatment of neurodegenerative diseases, hematologic malignancies, and other inflammatory diseases.
CFO David J. Moss co-founder, has been with the company since its formation in September 2015. He holds an MBA from Rice University and a bachelor's degree in economics from the University of California, San Diego. Moss has founded, funded and taken public various companies in a variety of industries since 1995.
Mark Lowdell, Ph.D. co-founder, has served as the chief scientific officer and chief manufacturing officer at INmune Bio since the company's formation. He is a professor of cell and tissue therapy at University College London where he has led a translational immunotherapy group since 1994. He has also been a director of cellular therapy at the Royal Free London NHS Foundation Trust. He received his Ph.D. in clinical immunology from London Hospital Medical College, University of London in 1992 and is a qualified immunopathologist.
Christopher J. Barnum is director of neuroscience at INmune Bio. Barnum is a neuroimmunologist with broad expertise across neurodegenerative and psychiatric diseases holding multiple positions in academic and industry. His focus has been on translating inflammatory therapies into clinical treatments for neurologic diseases using a biomarker-directed approach. Barnum's research has been supported by the NIH, the Michael J. Fox Foundation, and the Alzheimer's Association. He received his Ph.D. in neuroscience from Binghamton University.
INmune Bio Inc. (OTC: INMB), closed Thursday's trading session at $6.19, up 0.814332%, on 17,270 volume with 145 trades. The average volume for the last 3 months is 45,379 and the stock's 52-week low/high is $5.05999994/$11.50.
- INmune Bio, Inc. (NASDAQ: INMB) Receives USPTO Allowance of Key Patent Covering DN-TNFa Platform Technology for Treating Cancer
- INmune Bio to Present at the H.C. Wainwright 21st Annual Healthcare Conference on Tuesday, September 10th at 2:10 p.m. ET
- INmune Bio Inc. (NASDAQ: INMB) Reports Positive Q2 2019 Financial Results
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)
Plus Products (CSE: PLUS) (OTCQB: PLPRF), a leading cannabis branded products company in California, on Wednesday announced its entry into an agreement with a certain arm’s length party with respect to the settlement of USD$1,044,806.03 owing or to be owing to such creditor for services rendered. To view the full press release, visit: http://nnw.fm/T5nF7.
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.
First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.
PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.
Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.
During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:
- Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
- Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
- Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
- Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
- Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
- Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.
“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”
The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.
Plus Products Inc. (PLPRF), closed Thursday's trading session at $3.454, up 1.663%, on 15,339 volume with 39 trades. The average volume for the last 3 months is 36,758 and the stock's 52-week low/high is $2.51999998/$6.00810003.
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Enters Agreement for Debt Private Placement
- Plus Products Proposed Shares for Debt Private Placement
- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) CEO to Present Live at VirtualInvestorConferences.com
HTC Extraction Systems (TSX.V: HTC)
HTC Extraction Systems (TSX.V: HTC) is a knowledgeable and prosperous gas, liquids and biomass extractor and refiner using patented technologies for extraction and distillation processes. To view the full article, visit: http://nnw.fm/L44ry.
HTC Extraction Systems (TSX.V: HTC) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.
Advanced Extraction Technologies
For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:
- LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
- PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
- Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.
Delta Purification® Technology
HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:
- Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
- Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
- Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.
Hemp Biomass and Tolling Contracts
HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.
Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.
Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.
The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.
Sales and Offtake Agreements
HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.
HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.
Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.
Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.
HTC Extraction Systems (TSX.V: HTC), closed Thursday's trading session at $0.74, up 1.3699%, on 22,000 volume with 8 trades. The average volume for the last 3 months is 221,514 and the stock's 52-week low/high is $0.079999998/$1.24.
- HTC Extraction Systems (TSX.V: HTC) Leveraging CBD Extraction, Refining Expertise to Become Major Industry Player
- Why HTC Extraction Systems (TSX.V: HTC) Is ‘One to Watch’
- HTC Extraction Systems (TSX.V: HTC) Poised for Growth in Biomass Processing After Farm Bill Legalizes Hemp
IONIC Brands Corp. (CSE: IONC) (OTC: IONKF)
IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3) recently acquired Natural Extractions Inc., which is doing business as Zoots Premium Cannabis Infused Edibles (http://nnw.fm/6SPDd). To view the full article, visit: http://nnw.fm/W3E9v.
IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) is a national cannabis holding company building a multistate portfolio of award-winning premium and luxury brands in the cannabis space. Established in 2015, IONIC Brands has demonstrated its ability to expand and operate multiple cannabis concentrate consumer brands in leading markets across the western United States, with current operations in Washington, Oregon, California and Nevada. The company continues to strategically expand nationwide to remain a leader of the highest-value segments in the cannabis market.
With a focus on quality, responsibility and respectability, IONIC’s product lines are pioneering the changing landscape of cannabis consumption. The company’s refinement practices are a result of a passionate commitment to craft the finest, small-batch cannabis oils and cannabis concentrates in the world – without glycols, glycerins or additives.
IONIC’s Certified Clean program verifies that every product leaving the company’s facilities meets or exceeds state mandates on pesticide testing. The testing is conducted by individually testing every batch which ensures and enhances trust and transparency. IONIC recently paired its Certified Clean program with Lucid Green Inc. and its revolutionary technology platform designed to provide vital safety information. Lucid Green’s technology provides a direct-to-consumer data platform, providing instant access to a library of product specific insights by simply scanning the package’s QR code with a smartphone camera.
Elite Brand Portfolio/Acquisitions
- IONIC, the company’s flagship recreational branded product, is a stylish and sophisticated premium vape pen line that has earned customer loyalty and a reputation as a consistent Top 10 vape brand in Washington state. IONIC’s immediate product line expansion plans include THC/CBD mixes, low-dose products, high-end edibles, CASK oil and device innovation.
- WW Agriculture cultivates cannabis outdoors on a 140-acre eastern Washington State farm capable of producing up to 100,000 pounds of cannabis for less than $0.10/gram.
- ZOOTS, a Washington-based edibles company, utilizes patent-protected ultra-clean CO2 extraction hardware to create proprietary formulations of refined cannabis oils and distillates. Through MedMen dispensaries, Zoots Edibles are currently available in Washington and Colorado and will soon be on shelves at dispensaries in Massachusetts, New York and Pennsylvania.
- Vuber Technologies hardware produces the best vaporization experience on the market.
- Vegas M Stick vaporizer pens are distributed to stores in Washington State with plans to expand to Oregon and Nevada.
- Vegas Valley Growers is a revenue-generating, vertically integrated operation in Las Vegas, Nevada, with a full complement of production, manufacturing and distribution licenses.
IONIC has also acquired two U.S. patents issued to Canna Café that are related to cannabinoid (CBD) infused coffee and CBD-infused coffee in a Keurig ® K-Cup ® Pod. An international patent is in process for cannabis-infused teas.
Experienced Management Team
IONIC Brands is led by an innovative product team, powerful sales organization and a world-class marketing group.
Chairman & CEO John Gorst has built and sold four different technology companies with market valuations in excess of $600 million. Gorst has been at the forefront of IONIC’s expansion and development into Washington state’s leading vaporizer brand.
Andrew Schell, President, Vice-Chairman & Co-Founder, has built several successful companies. Schell has an engineering background rounded in operations, strategy and corporate law, and most recently was CEO of a U.S. Department of Defense company specializing in military operations.
Christian Struzan, Chief Marketing Officer & Co-Founder, has over 30 years of experience in marketing and branding in the entertainment and consumer goods industries. Struzan founded an advertising agency which developed and executed marketing campaigns for feature films such as the Star Wars franchise, Fight Club, and the television series American Idol. He has also worked on global brands such as Guinness, Stella Artois and Beck’s.
Johnny Stange, Chief Revenue Officer, was formerly a director of sales for the southern California region for Treasury Wine Estates, a major wine wholesaler, where he grew and oversaw annual sales of $250 million. Stange is leading the charge in IONIC’s aggressive sales growth plans across multiple states.
In 2018, IONIC was voted one of the “Top 50 Companies to Work for in Cannabis” by MG Magazine, a publication serving cannabis industry professionals.
IONIC Brands Corp. (OTC: IONKF), closed Thursday's trading session at $0.0999, up 22.0227%, on 264,794 volume with 39 trades. The average volume for the last 3 months is 218,035 and the stock's 52-week low/high is $0.035999998/$0.634559988.
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Strengthens Offerings via Acquisition of Cannabis-Infused Edibles Line
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Enhances Portfolio with VVG Acquisition
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Releases Fiscal 2019 Q2 Financial Results, Achieves $5.9M Revenue Milestone
VPR Brands, LP (VPRB)
Based in Fort Lauderdale, Florida, VPR Brands LP (OTCQB: VPRB) is a technology holding company with experienced management. The company’s assets include issued U.S. and Chinese patents for atomization-related products, including technology for medical-marijuana vaporizers and electronic-cigarette products and components.
Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.
VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:
- GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit www.cbdgoldline.com.
- HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit www.vapehoneystick.com.
- Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
- Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
- Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
- GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit www.goldlinehemp.com for more information about GoldLine Hemp-only products.
- Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.
CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.
Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.
VPR Brands, LP (VPRB), closed Thursday's trading session at $0.06, up 9.0909%, on 53,250 volume with 9 trades. The average volume for the last 3 months is 126,765 and the stock's 52-week low/high is $0.033799998/$0.119999997.
- VPR Brands LP (VPRB) Focusing on Innovative Product Family, Cannabis Concentrates and Extracts
- VPR Brands LP (VPRB) Announces Intention to Enforce and Monetize U.S. Utility Patent for Electronic Cigarette
- VPR Brands LP (VPRB) Readies for Q3 Debut of JUST Batteries Vape Line, Relaunch of KRAVE E-Cigarettes
Sugarmade, Inc. (SGMD)
Sugarmade Inc. (OTC:SGMD) today announces its placement in an editorial published by CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company for private and public entities in the cannabis industry. To view the full publication, titled “Hemp Set to Overtake Tobacco in Kentucky Amid Boom for Growers, Suppliers,” visit: http://cnw.fm/rWM36.
Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.
Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.
Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.
Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.
Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.
Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.
Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.
CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.
Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.
Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6
Sugarmade, Inc. (SGMD), closed Thursday's trading session at $0.0163, up 5.1613%, on 6,122,590 volume with 153 trades. The average volume for the last 3 months is 4,297,142 and the stock's 52-week low/high is $0.00975/$0.164000004.
- Sugarmade Inc. Featured in CNW Publication Discussing Hemp as Kentucky’s Top Crop
- Hemp Set to Overtake Tobacco in Kentucky Amid Boom for Growers, Suppliers
- Sugarmade Inc. (SGMD) Launches Advanced iPower Cultivation Equipment on Amazon.com
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
OrganiGram Holdings Inc. (TSX:OGI) (NASDAQ:OGI) was highlighted today in a publication from Livemoney, examining how the CBD story is exploding. At current pace, The Brightfield Group says CBD sales could explode to $23.7 billion by 2023.
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint.
The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.
In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.
Significant Expansion Plans with Streamlined Licensing Process
Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.
In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.
The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.
Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.
Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products
Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.
Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.
Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.
The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.
Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.
Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.
Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.
Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.
Experienced Executive Team
- CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
- Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
- Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
- Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
- Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.
This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.
1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.
Organigram Holdings Inc. (NASDAQ: OGI), closed Thursday's trading session at $4.54, off by 4.0169%, on 767,200 volume with 2,678 trades. The average volume for the last 3 months is 1,030,454 and the stock's 52-week low/high is $2.97000002/$8.43999958.
- This is Why Top Retailers are Racing to be a Part of the Cannabis Boom
- Evolving Cannabis Cultivation Smart Farming Technology Producing Better Strains
- Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) Receives Health Canada Approval to Bring Moncton Facility’s Annualized Licensed Capacity to 76,000 kg Target
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TSX:TGOD) (US:TGODF), a leading producer of premium certified organic cannabis, is pleased to announce that following its launch in Ontario at the end of August, which marked the Company's entrance into Canada's recreational market, initial demand has exceeded expectations. TGOD's high-THC signature strain, Unite Organic, is performing well online and at dispensaries, triggering a second order from the OCS earlier than initially anticipated.
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at email@example.com
The Green Organic Dutchman (OTC: TGODF), closed Thursday's trading session at $2.03, off by 1.6949%, on 437,316 volume with 640 trades. The average volume for the last 3 months is 599,232 and the stock's 52-week low/high is $1.60699999/$7.89379978.
- The Green Organic Dutchman Confirms Strong Demand for Premium Organic Cannabis Following Ontario Launch; Accelerates Shipments
- BMO Completes Placement of The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Block
- The Green Organic Dutchman and Caliper Foods Report Positive Results from Pharmacokinetic Study of Proprietary Water-Soluble Cannabinoid Technology
Cannabis Strategic Ventures, Inc. (OTCQB: NUGS)
Los Angeles-based Cannabis Strategic Ventures Inc. (OTC: NUGS) (the “Company”) announced today the appointment of four new directors to the Company’s board of directors, one of which will assume the role of board chairman. These new appointments were made in accordance with the Company’s commitments in its strategic investment agreement with LW Ventures Inc., which has already yielded an $8 million financing commitment toward the scaling of operations at the Company’s wholly owned and operated flagship greenhouse farm, NUGS FARM.
Cannabis Strategic Ventures, Inc. (OTCQB: NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.
The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.
Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.
Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.
Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.
Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.
Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.
The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.
Cannabis Strategic Ventures, Inc. (OTCQB: NUGS), closed Thursday's trading session at $0.31, off by 11.4286%, on 49,810 volume with 24 trades. The average volume for the last 3 months is 101,876 and the stock's 52-week low/high is $0.25/$4.84000015.
- Cannabis Strategic Ventures Announces Appointment of New Directors, Chairman to Corporate Board
- Cannabis Strategic Ventures Announces First Sales from NUGS FARM Cultivation, Manufacturing and Distribution Facility
- 420 with CNW – LA Launches Crackdown on Marijuana Black Market
Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)
Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) today announces its placement in an editorial published by CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company for private and public entities in the cannabis industry. To view the full publication, titled “Technological Innovation Pushes Bounds of Edible Cannabis Market,” please visit: http://cnw.fm/9nHVN.
Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.
To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.
This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.
Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.
Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.
Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.
Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.
President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.
Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.
Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.
Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.
Sproutly Canada, Inc. (OTCQB: SRUTF), closed Thursday's trading session at $1.05, off by 2.3256%, on 305,561 volume with 248 trades. The average volume for the last 3 months is 390,934 and the stock's 52-week low/high is $0.850000023/$2.03999996.
- Sproutly Featured in CannabisNewsWire Publication on Tech Innovation in Edible Cannabis Space
- Technological Innovation Pushes Bounds of Edible Cannabis Market
- Infusion Biosciences Develops Breakthrough Testing Methods to Detect Cannabinoids in Water Solutions to Meet Food and Safety Standards
Marijuana Company of America Inc. (MCOAD)
Innovative hemp and cannabis corporation Marijuana Company of America (OTCQB: MCOA, MCOAD) recently introduced its new joint venture, a premium-cannabis delivery service called VivaBuds, through a virtual launch party. To view the full article, visit: http://nnw.fm/uFA5S. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. The former head of the FDA has said that the conflict between the federal and state marijuana laws has created regulatory gaps which have given chance to tainted or substandard products to enter the market, resulting in the fatal lung injuries that have been reported recently. He hinted that federal action could put an end to this problem.
Marijuana Company of America Inc. (OTC: MCOAD) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.
The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.
The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.
The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.
Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.
Marijuana Company of America Inc. (MCOAD), closed Thursday's trading session at $0.2256, off by 4.00%, on 217,971 volume with 176 trades. The average volume for the last 3 months is 87,982 and the stock's 52-week low/high is $0.023/$2.10599994.
- Marijuana Company of America Inc. (MCOAD) Joint Venture Provides Low-Cost, Premium-Cannabis Delivery
- 420 with CNW – Former FDA Boss Hints Marijuana Legalization Is Necessary for Public Health Reasons
- Marijuana Company of America Completes Reverse Stock Split
Grapefruit Boulevard Investments Inc. (IGNG)
Grapefruit Boulevard Investments Inc. (IGNG) was highlighted today in a publication by Wall Street PR.
Grapefruit Boulevard Investments Inc., a California corporation (“Grapefruit”), as of May 31, 2019, is a wholly owned subsidiary of Imaging3 Inc. (OTC: IGNG), a Delaware corporation whose shares of $.001 par value common stock are publicly traded on the OTCMarkets OTCQB Market under the symbol “IGNG.” IGNG is subject to the reporting requirements of the Securities Exchange Act of 1934 and files annual and quarterly reports pursuant thereto. Grapefruit holds licenses originally issued by the State of California in January 2018 to both manufacture and distribute cannabis products. Grapefruit’s management now owns a controlling interest in IGNG which now owns 100% of Grapefruit’s outstanding shares. As a result, IGNG’s financial reports will consolidate both IGNG’s and Grapefruit’s balance sheet, statement of operation and statement of cash flows and IGNG and Grapefruit will be operated as a single company. IGNG intends to change its name to Grapefruit and to obtain a more appropriate trading symbol as soon as possible. Hereinafter the combined companies will be referred to as “Grapefruit” or the “Company.”
Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds licenses to both manufacture and distribute cannabis products which were originally issued in January 2018 and is fully compliant with all applicable laws and regulations to operate its cannabis manufacturing and distribution businesses.
The company is well-focused on sourcing only the “best of the best” raw cannabis materials to create the highest quality, most-trusted and consistent recreational and medical cannabis products for its customers. Grapefruit is committed to ensuring class-leading quality by rigorously testing the purity and potency of its raw materials throughout the manufacturing process and distribution chain.
Grapefruit owns and operates its fully licensed and compliant ethanol extraction laboratory located in the Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. The company’s extraction lab produces high quality, cannabis-derived distillate, also known as “honey oil,” from cannabis flower and “trim.” THC honey oil is one of base cannabis commodities which serves as the active ingredient in everything from infused edibles and tinctures/creams to the cartridges used in vapes and e-cigarettes. Honey oil often sells on the wholesale marketplace for thousands of dollars per liter, with pricing being dependent on quantity purchased, as well as other market factors such as the availability and cost of the underlying flowers and/or trim.
Grapefruit began its extraction operations in May 2019. Plans are in place to expand its honey oil production through the purchase of additional distillation equipment, which is expected to significantly increase the company’s production capacity by the fourth quarter of 2019. Grapefruit’s extraction lab is fully scalable and expansion will be built-out on a two-acre lot owned by Grapefruit at the Coachillin’ site adjacent to its current manufacturing and distribution operation.
Grapefruit selected the City of Desert Hot Springs for its cannabis extraction laboratory, because the city has created a friendly business environment for cannabis-based manufacturers, including incentives like the absence of taxes on cannabis oil production revenues. This affords Grapefruit a fundamental competitive market advantage over other Honey Oil producers.
The California cannabis regulatory scheme is unique in that it requires all cultivators (cannabis farms) and manufacturers (whether producing oils/distillates, infused edibles, tinctures creams or other cannabis products) to sell their products into the legal cannabis wholesale and retail markets exclusively through licensed distributors such as Grapefruit. Grapefruit initially obtained its California recreational and medicinal cannabis distribution license Jan. 4, 2018. In May 2019, Grapefruit was granted its provisional distribution license which is renewable annually, thereby cementing the regulatory foundation necessary to rapidly expand its distribution business.
Grapefruit’s distribution license affords it a twofold strategic advantage: first, to market and sell its own cannabis product lines to retailers throughout California; and second, to buy and resell bulk cannabis flowers and trim as well as all other legal cannabis products to properly licensed distributors and/or retailers throughout California.
The Coachillin’ Canna-Business Park, home to Grapefruit’s current operating facilities and adjacent two-acre parcel of land, is a 160-acre, self-contained legally mapped compound providing the Company with a fully permitted and serviced physical plant from which Grapefruit intends to establish a leading position in the booming California cannabis sector. The parcel was purchased by the Company prior to the Park’s full development, and the value of the land the Company owns has conservatively since doubled in value to over $2 million. Additional long-term benefits of the Coachillin’ compound include agricultural rates for power, which are currently $0.09 per kilowatt hour; the Park’s deep-water well that fully satisfies its need for water; and security expenses shared by all resident businesses. The Coachillin’ Park’s promoters also plan to position the Park, located only 10 miles north of rapidly growing uptown Palm Springs and less than 15 miles from the site of the Coachella and Stagecoach music festivals as a must-see canna-tourism destination.
Grapefruit’s ultimate goal is to become a vertically integrated, seed-to-sale cannabis and CBD product company serving the California market. Moreover, it plans to roll-out its product lines in other states, such as Nevada, Illinois, Oregon, Colorado and Washington. Grapefruit has plans to build a large, all-inclusive facility that will house a 50,000-square-foot-plus indoor grow canopy, a large extraction laboratory designed to extract both THC and CBD cannabinoids via non-volatile (ethanol) and volatile (butane) processes, a manufacturing space to produce Grapefruit’s vape lines and CBD products, an FDA-certified kitchen for the production of Grapefruit edibles and a distribution facility to sell all products into the entire cannabis market. The indoor grow canopy operation will be outfitted and operated to produce ultra-high-quality flowers and buds, some of which, along with the high-quality trim resulting from cleaning and maintaining the grow, will provide biomass necessary to feed the company’s extraction laboratory. Fueled by this hand cultivated biomass, Grapefruit’s lab will continuously produce pesticide and heavy metal-free world class honey oil to both serve as the active ingredient in all of Grapefruit’s branded and unbranded products and meet the projected ever-growing demand for high quality honey oil in the California market.
Grapefruit’s motto – A High You Can Trust – embodies its philosophy and ethos, reminding consumers of the company’s commitment to manufacturing, procuring and distributing only the highest quality all-natural cannabis flower, concentrates and related products that are free from pesticides, heavy metals and bacteria. Grapefruit will target its products to all recreational cannabis enthusiasts’ as continuous, consistent cannabis products. By relentlessly adhering to these policies Grapefruit intends to become the Titleist of the Cannabis industry, known for unwavering quality and consistency.
Grapefruit is managed by a team of experts possessing the experience, skill and resources required to succeed in the competitive cannabis marketplace. Founded by brothers Bradley Yourist, CEO, and Daniel Yourist, COO, Grapefruit has expanded to become a group of industry professionals sharing a passion for all things cannabis. Both the CEO & COO are attorneys licensed to practice law the State of California who possess expert cannabis licensing and regulatory expertise and experience, which will allow Grapefruit to deftly navigate the ever changing California regulatory landscape and apply for new cannabis licenses at reduced costs when necessary, rather than having to acquire licenses that are often overvalued and/or pay outside counsel to handle such matters.
Grapefruit also has its own line of cannabis-infused concentrates and edibles. Among the brands now in stores or soon to be launched are:
- Rainbow Dreams is a new lifestyle brand designed specifically for the recreational cannabis marketplace. The Rainbow Dreams brand captures the anything goes party vibe of the 1970s by offering an array of cannabis products, such as a line of vape carts with unique cannabis strains combined with all-natural flavors for a superior no-burn experience. Rainbow Dreams fills an important niche in the marketplace as a top shelf quality product line that is competitively priced.
- Sugar Stoned, which Grapefruit acquired in the winter of 2018, has always been a popular cannabis edibles brand which terminated operations when recreational cannabis became legal and required a license in California. Grapefruit purchased the Sugar Stoned brand in 2019 and it is now a Grapefruit portfolio brand consisting of a premium quality cannabis-infused gummy line with eight different flavors: blue raspberry, cherry, grape, peach, pineapple, sour apple, strawberry and watermelon. Grapefruit intends to expand the brand in the near future through the release of a variety of infused cookies.
Grapefruit Boulevard Investments Inc. (IGNG), closed Thursday's trading session at $0.214, off by 10.4603%, on 2,013,675 volume with 385 trades. The average volume for the last 3 months is 234,243 and the stock's 52-week low/high is $0.006095/$0.358999997.
- The Daily Buzz: The Stocks to Watch RIGHT NOW! (ZS, TCNNF, IGNG)
- Grapefruit Announces Appointment of Justin Costello as its Initial Corporate Advisor
- Grapefruit Boulevard Investments Inc. (IGNG) Engages Singer Lewak in 2018/2019 Audits
Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P)
Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: A2PL), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced the launch of its new exclusive brand of cannabidiol (“CBD”) product lines: BIS (“Be In Synergy”). To view the full press release, visit: http://nnw.fm/gD27T.
Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P), dba Innovative Properties Inc., is a Canadian investment company pursuing interests in high-quality cash-flow assets in real property, securities, cryptocurrency and all branches of the cannabis sector. The company's focus on strategic revenue generation, EBITDA and growth is enshrined in its moto, "One team. One goal," and is reflected in its name: "Na bis," which is defined as, "repeat performance" or "encore."
While the Nabis' targets span numerous industries, the company aims to establish an Anchor Investment Portfolio primarily through the acquisition of majority interests in high quality U.S. cannabis assets and brands that have achieved cash flow. The company will then employ a hands-on approach to assist the investee in implementing standards and consistency to enhance their operations.
Criteria for investment targets are as follows:
- Positive EBITDA, vertically integrated operators in limited license states with large addressable markets
- Emphasis on operations that add material EBITDA within 12 months with enhanced access to capital and Nabis' value add approach on operations and brand consistency
- Identifying proven operators with good expertise to add value to a consolidation strategy
- Focused on MSOs (Multi-state Operators) with strong brand traction
- Pharma grade cultivation, extraction, dispensaries and other addressable operations
Nabis has completed investments in five Michigan properties with Cannabis provisioning, processing and cultivation licenses. The Company has also entered into binding Letters of Intent ("LOI") to invest in vertically integrated assets in Michigan, Arizona and Washington State. The company's goal is to be invested in four to five additional states in the coming months.
Arizona – LOI to acquire full control of Organica Patient Group Inc. ("OPG") and RDF Management Group. OPG is a fully integrated medical marijuana business licensed under the provisions of the Arizona Medical Marijuana Act. Its assets include the Chino Valley MMJ Dispensary and fully established Patient Group, which since 2012 has operated as "Organica Patient Group" in Chino Valley. OPG also operates a 26,000-square-foot indoor cultivation and processing center along with a 56,600-square-foot greenhouse in Prescott Valley; has its own branded products and wholesale operations which includes distribution to more than 25% of the dispensaries in Arizona; and has exclusive manufacturing and licensing agreements with Fire Brand, Gas Extracts and Donuts Concentrate products distributed within Arizona.
Michigan – LOIs to invest in multiple strategically located properties that have or are eligible for municipal approvals for provisioning centers in Michigan. The company is currently evaluating 10 to 15 additional municipally approved locations in Michigan that would substantially increase the company's overall presence in the U.S. cannabis space.
Washington State – LOI to purchase assets from PDT Technologies LLC, including extraction and production equipment and rights to lease the current production facility in Port Townsend, Wash. The LOI includes licensing rights to produce Chong's Choice Brand CO2 Vape Cartridges, one of the leading and most recognizable brands in the cannabis space. Expansion plans include construction of a new ISO designed extraction clean room and GMP lab facility with new, highly specialized equipment with two extraction lines. The facility could produce up to 20,500 kg of cannabis concentrate on an annual basis.
Hivemind Refinery – LOI to invest in a 70% interest of Hivemind Refinery, an established line of CBD-based wellness products in the United States. The investment into Hivemind expands Nabis' investment portfolio to CBD edibles, water, drops, lotions, and other CBD wellness products across the spectrum. Nabis anticipates Hivemind will be a premium consumer CBD line to be distributed across the U.S. and Canada and will focus on products utilizing locally grown, premium CBD along with unique formulations and delivery systems.
Bloombox – binding term sheet with Momentum Ideas Co. to acquire certain assets used and marketed under the brand "Bloombox," a leading intelligent retail cannabis software platform that includes the Bloombox Software and data platform. The acquisition of Bloombox will create a dominating presence in the U.S. cannabis market, featuring an integrated ecosystem of modern, next-generation cannabis technology. Bloombox is one of the world's first standards-based cannabis software systems, enabling frictionless integration with nearly any business system or regulatory body.
Proven Management Team
CEO and Director Shay Shnet has over 20 years of experience in business and was most recently a founding partner and vice president of operations of MPX Bioceutical (CSE: MPX). While at MPX, Shnet focused on the North American cannabis space and helped build the company's portfolio of international cannabis assets. He is highly skilled in finding unique opportunities and has been directly involved with the development, branding, importing, consumer packaging and distribution of a wide variety of product lines.
President Mark Krytiuk is a very successful cannabis operator and was a founding partner of MPX. As the vice president of grow operations of MPX, he oversaw the production of medical marijuana and pharma-grade products across North America. He has been directly involved in overseeing the rapid expansion and buildout of nine facilities in three countries with budgets ranging up to $30 million. Krytiuk's experience includes consulting and working with customers to develop individual requirements for indoor and outdoor cannabis cultivation while working with federal regulators and licensing bodies to ensure compliance.
Nabis Holdings (OTC: NABIF), closed Thursday's trading session at $0.0782, off by 21.80%, on 1,046,013 volume with 79 trades. The average volume for the last 3 months is 105,609 and the stock's 52-week low/high is $0.07/$0.791499972.
- Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: A2PL) Launches New Exclusive CBD Brand
- Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: A2PL) Acquires Cultivation, Fulfillment and Production Facility, Expands Arizona Footprint
- Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: A2PL) Announces Board Member Resignation
Neutra Corp. (OTCQB: NTRR)
Neutra Corp. (OTCQB: NTRR), an early stage research and development company focusing on modern healthy living solutions, is concentrating on developing into a vertically integrated company able to cultivate, manufacture and distribute hemp-based cannabidiol (CBD) products. Recently announced tactical acquisitions make the company’s intentions clear, as Neutra Corp. CEO Sydney Jim detailed in a recent interview (http://nnw.fm/gZ3jU).
Neutra Corp. (OTCQB: NTRR) is an early-stage research and development company bringing modern healthy living solutions to a multi-billion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture – one where consumers are demanding access to products that promote health and stave off potential health dangers.
Neutra is concentrating on developing into a vertically integrated company able to cultivate, manufacture and distribute hemp-based cannabidiol (CBD) products. Hemp-based CBD consumer products generated sales of up to $390 million in 2018 with projections pointing to a $3 billion market by 2022, according to the Hemp Business Journal.
Neutra’s new broadened scope, which includes the commercialization of newer, more effective products, aims to capitalize on this worldwide boom. Our company is seeking new and exciting opportunities that can accelerate Neutra’s mission to bring these products to a wider demographic. Our work reflects a renewed dedication to supporting a better body, environment and life for people around the globe.
- Vivis – Neutra is expanding its market presence in the rapidly growing hemp-derived CBD market with a letter of intent to acquire Vivis, an emerging retail brand of hemp-based health and nutritional products. Vivis’ hemp-derived CBD products are third-party certified as contaminant-free and of consistent quality and potency. Consumers are increasingly looking for this certification when they buy hemp-based CBD products. With Vivis as the new retail face of Neutra, the company is expecting greater interest in its expanding portfolio of branded products moving to market.
- J3 Holdings – The signing of a letter of intent to acquire J3 Holdings includes the company’s land and warehouse, as well as a license to cultivate hemp and refine it into usable forms. Neutra has concentrated its early efforts developing business networks and on developing hemp-based CBD products, including supplements and creams. The latest move will enable the company to grow its own hemp supply, giving it more control over the quality of its ingredients.
- Surface to Air Solutions is the North American distributor of a patent-pending, water-based solution known as Purteq, a green technology that works similar to photosynthesis.
- ZeroBlast uses a durable, non-toxic, anti-microbial solution to eliminate all contaminates and kill germs on contact for a period of up to 90 days.
Neutra president and CEO Sydney Jim provides strong executive leadership, a network of business contacts and experience implementing solid corporate strategy. Jim has a proven track record of adding value for public company shareholders. He founded Global Visionary Investments where operational support is provided to seven different companies and their subsidiaries. Jim was also the CEO of First Titan Energy, a microcap public company where he was responsible for restructuring the corporate structure, deal sourcing, and leading the company in mergers and acquisitions.
Dr. Scott Cherry is the company’s sports performance medical advisor. He is an energetic physician executive with a passionate focus on health, performance and prevention. Dr. Cherry received emergency medical technician training in the U.S. Navy, a bachelor’s degree in chemistry from Florida State University, medical degree from Nova Southeastern University, and a master’s degree of public health from Uniformed Services University F. Edward Herbert School of Medicine. Dr. Cherry has honed his skills in a variety of medical and executive positions spanning the U.S. Army and Navy, several Fortune 500 corporations, and major health care facilities over the past 20 years.
Neutra Corp. (OTCQB: NTRR), closed Thursday's trading session at $0.00195, off by 15.2174%, on 31,072,485 volume with 140 trades. The average volume for the last 3 months is 22,969,085 and the stock's 52-week low/high is $0.0012/$0.099899999.
- Neutra Corp. (NTRR) Strengthens its Health and Nutritional Product Line with Strategic Purchase of Emerging CBD Retail Brand
- Neutra Corp. Positioned to Grab Sizeable Share of Soaring CBD Market with VIVIS Acquisition
- Neutra Corp. (NTRR) Adding Hemp-Derived CBD Product Retail Brand to Portfolio
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) CEO Rings Nasdaq Opening Bell
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) Announces First Sales from NUGS FARM Cultivation, Manufacturing and Distribution Facility
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Launches Strategic Advisory Board
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) 420 with CNW – The American Bar Association Asks Congress to Pass Legislation Allowing States to Enact Their Own Cannabis Laws
- ChineseInvestors.com (CIIX) Announces Subsidiary’s Launch of Six New Hemp-Infused Skincare Offerings
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) to Acquire 19.9% Equity Interest of Coastal Green, a BC-Based Cannabis Retailer
- City View Green (CSE: CVGR) (OTCQB: LRZZF) Achieves Listing, Commences Trading on OTCQB Venture Market
- CloudCommerce (OTCQB: CLWD) Introduces SWARM Solution to Data-Driven Marketing
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Cool Events Inc. (RNWR) Updated Reports Covering Strong Attendance at Signature Fun Runs
- Earth Science Tech, Inc. (ETST) Names Pharmaceutical and Orthopedic Expert as Head of New Sales Division
- Endonovo Therapeutics (OTCQB: ENDV) Partners with Veterans Healthcare Supply Solutions, Appoints Samir Awad, M.D., to Scientific Advisory Board
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Eye-Net Mobile Successfully Completes Controlled-Environment Trial for the Connected Car Division of a Leading Global Vehicle Manufacturer
- Genprex, Inc. (NASDAQ: GNPX) Independent Researchers Find Genprex’s TUSC2 Prevents Tumor Growth in Triple-Negative Breast Cancer
- Geyser Brands Inc. (TSX.V: GYSR) NanoFusion Technology Provides Competitive Edge
- Grapefruit Boulevard Investments Inc. (IGNG) Announces Appointment of Justin Costello as its Initial Corporate Advisor
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Cannabis Stocks Sector Snapshot - Viva Las Vegas - Industry Growth In Nevada
- Green Hygienics Holdings Inc. (GRYN) 420 with CNW – The Benefits of Marijuana During Breast Cancer Treatment
- Hemptown USA - Advances Growth Strategy via Nutraceutical Manufacturing Facility Acquisition
- HTC Extraction Systems (TSX.V: HTC) Is ‘One to Watch’
- INmune Bio, Inc. (NASDAQ: INMB) to Present at the H.C. Wainwright 21st Annual Healthcare Conference on Tuesday, September 10th at 2:10 p.m. ET
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) Enhances Portfolio with VVG Acquisition
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) Technological Innovation Pushes Bounds of Edible Cannabis Market
- Marijuana Company of America Inc. (MCOAD) Completes Reverse Stock Split
- MustGrow Biologics Corp (CSE: MGRO) Obtains Exclusive Rights of Streptomyces Bio-Fungicide Product Used to Treat Powdery Mildew in Cannabis Production
- Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P) Acquires Cultivation, Fulfillment and Production Facility, Expands Arizona Footprint
- Neutra Corp. (OTCQB: NTRR) Positioned to Grab Sizeable Share of Soaring CBD Market with VIVIS Acquisition
- Nightfood, Inc. (OTCQB: NGTF) Delivers Update on Recent Activities and Developments
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) Evolving Cannabis Cultivation Smart Farming Technology Producing Better Strains
- ORHub Inc. (ORHB) Settles Litigation with Former Chief Financial Officer
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Announces Drilling Results that Confirm and Extend High-Grade Nickel-Cobalt Mineralization
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Clean Oil Recovery Technology Transforms Heavy Oil Recovery
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Proposed Shares for Debt Private Placement
- Predictive Oncology Inc. (NASDAQ: POAI) Why POAI Is ‘One to Watch’
- Pressure BioSciences Inc. (PBIO) PCT Platform Identified as Pivotal for Cancer Biomarker Discovery and for Potential Clinical Diagnostics
- Quest Patent Research Corp. (QPRC) Creating Shareholder Value with Growing Intellectual Property Asset Portfolios
- Sharing Services Global Corporation (SHRG) Adds Value to Management Team with New Appointments
- SinglePoint, Inc. (SING) Running Circles Around the Competition - SinglePoint and Convectium: Investing in Cannabis Packaging Speed
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Announces US County Increases Uniden® UV350 Purchase Order to Over $1.0 Million
- Spectrum Global Solutions, Inc. (SGSI) Sees Strong Revenue Growth During Q2 2019
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Technological Innovation Pushes Bounds of Edible Cannabis Market
- SRAX Inc. (NASDAQ: SRAX) Coverage Initiated for SRAX Inc. via NetworkNewsWire
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Announces Delivery of Phases 1 & 2, Begins Installation of Direct Lithium Extraction Demonstration Plant
- Sugarmade, Inc. (SGMD) Hemp Set to Overtake Tobacco in Kentucky Amid Boom for Growers, Suppliers
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Focuses on Creating Transformative Businesses, Products and Brands
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) BMO Completes Placement
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) International Patent Application for TherOZap(TM) Enters National Phases in the US, Europe & Canada
- TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Releases Corporate Update
- Trxade Group Inc. (TRXD) Providing Bulwark of Small Pharmacy Security Amid Challenging Health Care Times
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Posts Q2 2019 Financial and Operating Results
- VPR Brands, LP (VPRB) Announces Intention to Enforce and Monetize U.S. Utility Patent for Electronic Cigarette
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Expands Product Offerings as CBD Becomes Mainstream in the Wellness Industry
- Willow Biosciences Inc. (CSE: WLLW) Highlighted in Comprehensive Research Report
- Youngevity International, Inc. (NASDAQ: YGYI) Khrysos Industries, Inc., a wholly owned subsidiary of Youngevity International Reveals State of the Art, Florida Based Hemp Processing and Manufacturing Facility
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.